Back to top

Philogen Publishes Shareholders’ Meeting Minutes and Highlights Targeted Cancer-Drug Focus

Philogen SpA ( ($IT:PHIL) ) has issued an announcement. Philogen S.p.A., an Italian-Swiss biotechnology group, focuses on developing targeted antic...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: